Doctor of philosophy Alpna Thrust from the University of Colorado suggested that silibinin, which is the main component of milk Thistle, may be a promising therapeutic compound for the treatment of lung cancer.
Alpna Thrust and her team found that treatment with silibinin stopped the spread of lung cancers in mice.
It became known that cancer is easier to apply to the damaged cells.
In a new study on animals, it became obvious that silibinin helps to remove distinctive markers, which indicate wounds, reducing the spread of cancer cells in the lungs.
Although this natural extract has been used for over 2000 years, mainly for the treatment of diseases of the liver and gallbladder, it is one of the first studies, which suggested that it can be used against cancer.
The final products of the enzymes COX2 and INOS are involved in inflammatory reactions and may contribute to tumor growth. DNA itself synthesizes the signal of other enzymes called STAT1 and STAT3. If you break the chain at this level, it will stop tumor growth.
"This is a relatively nontoxic substance is a derivative of milk Thistle called silibinin is able to suppress the signals contributing to the formation of harmful enzymes," said Rod.
This natural medicine is much cheaper than existing and helps to stop the migration of an existing cancer.